4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0002040705-26-000002
Options or other derivatives
- Chief Financial Officer acquired 26,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DeLucia David · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-03 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +26,000 | 26,000 | D |
Loading xslF345X05/form4-02062026_020236.xml…